Xiaoli Kong

1.4k total citations
41 papers, 1.1k citations indexed

About

Xiaoli Kong is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Xiaoli Kong has authored 41 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 17 papers in Cancer Research and 16 papers in Pathology and Forensic Medicine. Recurrent topics in Xiaoli Kong's work include Breast Lesions and Carcinomas (11 papers), Breast Cancer Treatment Studies (10 papers) and Cancer Mechanisms and Therapy (5 papers). Xiaoli Kong is often cited by papers focused on Breast Lesions and Carcinomas (11 papers), Breast Cancer Treatment Studies (10 papers) and Cancer Mechanisms and Therapy (5 papers). Xiaoli Kong collaborates with scholars based in China, United States and Switzerland. Xiaoli Kong's co-authors include Qifeng Yang, Ning Zhang, Yan Shi, Cunzhong Yuan, Yiran Liang, Xiaoyan Li, Yaming Li, Yuting Sang, Hanwen Zhang and Ying Liu and has published in prestigious journals such as PLoS ONE, Bioresource Technology and Oncogene.

In The Last Decade

Xiaoli Kong

38 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiaoli Kong China	19	589	444	286	240	114	41	1.1k
Yi-Ji Liao China	15	859 1.5×	506 1.1×	237 0.8×	93 0.4×	175 1.5×	20	1.3k
Guoqiang Zhang China	23	833 1.4×	625 1.4×	222 0.8×	232 1.0×	122 1.1×	57	1.3k
Piotr Potemski Poland	20	500 0.8×	266 0.6×	621 2.2×	103 0.4×	143 1.3×	119	1.4k
Hye Kyung Hong South Korea	20	432 0.7×	297 0.7×	442 1.5×	125 0.5×	118 1.0×	39	954
Chao Su China	18	571 1.0×	224 0.5×	206 0.7×	232 1.0×	144 1.3×	44	976
Anja Rabien Germany	20	843 1.4×	521 1.2×	342 1.2×	106 0.4×	309 2.7×	43	1.4k
Wenting Pan China	21	840 1.4×	634 1.4×	163 0.6×	75 0.3×	116 1.0×	65	1.2k
Mingsheng Zhang China	13	584 1.0×	240 0.5×	392 1.4×	139 0.6×	186 1.6×	29	1.1k
Nan You China	19	656 1.1×	410 0.9×	250 0.9×	91 0.4×	139 1.2×	61	1.3k

Countries citing papers authored by Xiaoli Kong

Since Specialization

Citations

This map shows the geographic impact of Xiaoli Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoli Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoli Kong more than expected).

Fields of papers citing papers by Xiaoli Kong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoli Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoli Kong. The network helps show where Xiaoli Kong may publish in the future.

Co-authorship network of co-authors of Xiaoli Kong

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoli Kong. A scholar is included among the top collaborators of Xiaoli Kong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoli Kong. Xiaoli Kong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liang, Yiran, Bing Chen, Long Li, et al.. (2024). LncRNA PRBC induces autophagy to promote breast cancer progression through modulating PABPC1-mediated mRNA stabilization. Oncogene. 43(14). 1019–1032. 6 indexed citations

Zhang, Peng, Xiaoli Kong, Jin‐Song Gong, et al.. (2024). Development of a platform strain for integration expression of phospholipase D and its application in improving phosphatidylserine content of egg yolk. Food Bioscience. 63. 105743–105743.

Liang, Yiran, Yajie Wang, Yan Zhang, et al.. (2023). HSPB1 facilitates chemoresistance through inhibiting ferroptotic cancer cell death and regulating NF-κB signaling pathway in breast cancer. Cell Death and Disease. 14(7). 434–434. 62 indexed citations

Ye, Fangzhou, Yiran Liang, Yajie Wang, et al.. (2023). Cancer-associated fibroblasts facilitate breast cancer progression through exosomal circTBPL1-mediated intercellular communication. Cell Death and Disease. 14(7). 471–471. 37 indexed citations

Zhang, Jing, Chang Su, Xiaoli Kong, et al.. (2022). Directed evolution driving the generation of an efficient keratinase variant to facilitate the feather degradation. Bioresources and Bioprocessing. 9(1). 38–38. 22 indexed citations

Wang, Zekun, Yaming Li, H. J. Yang, et al.. (2022). Circ-TRIO promotes TNBC progression by regulating the miR-432-5p/CCDC58 axis. Cell Death and Disease. 13(9). 776–776. 25 indexed citations

Kong, Xiaoli, Long Chen, Bo Li, Changyun Quan, & Jun Wu. (2021). Applications of oxidized alginate in regenerative medicine. Journal of Materials Chemistry B. 9(12). 2785–2801. 57 indexed citations

Liang, Yiran, Feng Yang, Xiaoyan Li, et al.. (2021). Evaluation of Carbon Nanoparticle Suspension and Methylene Blue Localization for Preoperative Localization of Nonpalpable Breast Lesions: A Comparative Study. Frontiers in Surgery. 8. 757694–757694. 6 indexed citations

Sang, Yuting, Xiaoli Kong, Xiaoyan Li, et al.. (2019). Langer's axillary arch lymph node metastasis in breast cancer patients: A prospective clinical study. Surgical Oncology. 29. 48–52. 5 indexed citations

10.

Jiang, Liyu, Xiaoyan Li, Xiaoli Kong, Tingting Ma, & Qifeng Yang. (2019). Galactogram Grading System for Identifying Breast Cancer With Nipple Discharge. Clinical Breast Cancer. 20(2). e214–e219.

11.

Kong, Xiaoli, Yi Duan, Yuting Sang, et al.. (2018). LncRNA–CDC6 promotes breast cancer progression and function as ceRNA to target CDC6 by sponging microRNA‐215. Journal of Cellular Physiology. 234(6). 9105–9117. 233 indexed citations

12.

Jiang, Liyu, Chuyu Jing, Xiaoli Kong, et al.. (2016). Comparison of adjuvant ED and EC-D regimens in operable breast invasive ductal carcinoma. Oncology Letters. 12(2). 1448–1454. 2 indexed citations

13.

Wang, Haiji, Xiaoli Kong, Xiaoyan Li, et al.. (2014). Trail Resistance Induces Epithelial-Mesenchymal Transition and Enhances Invasiveness by Suppressing PTEN via miR-221 in Breast Cancer. PLoS ONE. 9(6). e99067–e99067. 35 indexed citations

14.

Kong, Xiaoli, Haiji Wang, Ning Zhang, et al.. (2014). MTDH Mediates Estrogen-Independent Growth and Tamoxifen Resistance by Down-Regulating PTEN in MCF-7 Breast Cancer Cells. Cellular Physiology and Biochemistry. 33(5). 1557–1567. 29 indexed citations

15.

Zeng, Yunhang, et al.. (2013). Effective Component in &-Amylase Preparation for Unhairing. Journal of the American Leather Chemists Association. 108(3). 86–93. 3 indexed citations

16.

Li, Xiaoyan, Xiaoli Kong, Xiangnan Kong, et al.. (2013). 53BP1 Sensitizes Breast Cancer Cells to 5-Fluorouracil. PLoS ONE. 8(9). e74928–e74928. 14 indexed citations

17.

Lin, Xiaoyan, Fengfeng Cai, Xiaoyan Li, et al.. (2013). Prognostic significance of mammalian sterile 20-like kinase 1 in breast cancer. Tumor Biology. 34(5). 3239–3243. 21 indexed citations

18.

Shi, Yan, Yu Wang, Qifeng Yang, et al.. (2013). Low-dose radiation-induced epithelial-mesenchymal transition through NF-κB in cervical cancer cells. International Journal of Oncology. 42(5). 1801–1806. 43 indexed citations

19.

Li, Xiaoyan, Xiaoli Kong, Qiang Huo, et al.. (2011). Metadherin enhances the invasiveness of breast cancer cells by inducing epithelial to mesenchymal transition. Cancer Science. 102(6). 1151–1157. 66 indexed citations

20.

Zhang, Ning, Xiaoli Kong, Yan Shi, Cunzhong Yuan, & Qifeng Yang. (2010). Huaier aqueous extract inhibits proliferation of breast cancer cells by inducing apoptosis. Cancer Science. 101(11). 2375–2383. 117 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact